First long-acting HIV treatment injections pass trial
Injections, that could one day be an alternative to daily pills for people living with HIV, have been shown to be effective in maintaining viral supression, bringing them one step closer to market. Results from ATLAS and FLAIR studies were presented today at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI).
Kat Smithson, Director of Policy and Campaigns, NAT (National AIDS Trust) said: “Constantly improving treatments for HIV have revolutionised the lives of people living with this condition. The potential for HIV to be successfully treated with an injection repeated every month, rather than pills taken every day, could be life-enhancing for many people. It will help with adherence to medication and allow people with HIV to get on with their lives."
"Although we are some way off this treatment being available to patients, we are excited about the potential for this to improve life for people living with HIV."
For more details or further comment, contact senior press officer Charlie Alderwick: email@example.com 020 7814 6727
NAT (National AIDS Trust) is the UK’s leading charity dedicated to transforming society’s response to HIV. We provide fresh thinking, expertise and practical resources. We champion the rights of people living with HIV and campaign for change.
Shaping attitudes. Challenging injustice. Changing lives.